Publication | Closed Access

Effects of miglitol, sitagliptin, and initial combination therapy with both on plasma incretin responses to a mixed meal and visceral fat in over-weight Japanese patients with type 2 diabetes. “The MASTER randomized, controlled trial”

Metabolic SyndromeNutritionDiabetes ManagementHealth PolicyDiabetesType 2Diabetes ComplicationsDiabetes MellitusPublic HealthMedicineInitial Combination TherapyVisceral Fat